Myriad Genetics, Inc. (LON:0K3W)
London flag London · Delayed Price · Currency is GBP · Price in USD
5.47
0.00 (0.00%)
At close: Jul 7, 2025

Myriad Genetics Revenue

Myriad Genetics had revenue of $195.90M USD in the quarter ending March 31, 2025, a decrease of -3.12%. This brings the company's revenue in the last twelve months to $831.30M, up 7.38% year-over-year. In the year 2024, Myriad Genetics had annual revenue of $837.60M with 11.21% growth.

Revenue (ttm)
$831.30M
Revenue Growth
+7.38%
P/S Ratio
0.58
Revenue / Employee
$307.89K
Employees
2,700
Market Cap
373.78M GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024837.60M84.40M11.21%
Dec 31, 2023753.20M74.80M11.03%
Dec 31, 2022678.40M-12.20M-1.77%
Dec 31, 2021690.60M133.60M23.99%
Dec 31, 2020557.00M-81.60M-12.78%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 42.56B
GSK plc 31.53B
Haleon 11.23B
Smith & Nephew 4.64B
ConvaTec Group 1.83B
Hikma Pharmaceuticals 2.50B
HUTCHMED (China) 503.39M
Indivior 905.57M
Revenue Rankings